Abstract
Patch clamp remains the gold standard for studying ion channel activity within cell membranes. Conventional patch clamp is notoriously low throughput and technically demanding making it an unsuitable technique for high-throughput screening (HTS). Automated patch clamp (APC) devices have done much to increase throughput and improve ease of use, particularly when using standard cell line cells such as HEK and CHO. In recent years, however, the use of human-induced pluripotent stem cells (hiPSCs) has become increasingly important, especially for safety screening in response to the Comprehensive In Vitro Proarrhythmia Assay (CiPA) initiative introduced in 2013. The goal of this initiative is to standardize assays, targets, and cell types. One part of the paradigm focuses on the use of APC and hiPSC cardiomyocytes. This chapter describes two automated patch clamp devices recording from up to 8 or 384 cells simultaneously using hiPSC cardiomyocytes. In the voltage clamp mode, voltage-gated Na+ (NaV), Ca2+ (CaV), and K+ (KV) channels could be recorded, and pharmacology using tetracaine, a NaV channel blocker, is described. Additionally, action potentials in the current clamp mode were recorded, and examples are shown including the effect of nifedipine, a CaV channel blocker. Detailed methods are provided for cell culture and harvesting of hiPSCs for use on APC devices. Protocols are also provided for voltage and current clamp recordings on the Patchliner, and voltage clamp experiments on the SyncroPatch 384PE APC instruments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Neher E, Sakmann B (1976) Single-channel currents recorded from membrane of denervated frog muscle fibres. Nature 260:799–802. doi:10.1038/260799a0
Dunlop J, Bowlby M, Peri R et al (2008) High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology. Nat Rev Drug Discov 7:358–368. doi:10.1038/nrd2552
Farre C, Haythornthwaite A, Haarmann C et al (2009) Port-a-patch and patchliner: high fidelity electrophysiology for secondary screening and safety pharmacology. Comb Chem High Throughput Screen 12:24–37. doi:10.2174/138620709787047966
Brüggemann A, George M, Klau M et al (2003) The NPC © Technology. Assay Drug Dev Technol 1:665–673
Brueggemann A, George M, Klau M et al (2004) Ion channel drug discovery and research: the automated Nano-Patch-Clamp © technology. Curr Drug Discov Technol 1:91–96
Brüggemann A, Stoelzle S, George M et al (2006) Microchip technology for automated and parallel patch-clamp recording. Small 2:840–846. doi:10.1002/smll.200600083
Jones KA, Garbati N, Zhang H, Large CH (2009) Automated patch clamping using the QPatch. In: Janzen WP, Bernasconi P (eds) High throughput screening: methods and protocols, 2nd edn. Humana Press, a part of Springer Science & Business Media, Totowa, pp 209–223
Mathes C, Friis S, Finley M, Liu Y (2009) QPatch: the missing link between HTS and ion channel drug discovery. Comb Chem High Throughput Screen 12:78–95. doi:10.2174/138620709787047948
Tao H, Santa Ana D, Guia A et al (2004) Automated tight seal electrophysiology for assessing the potential hERG liability of pharmaceutical compounds. Assay Drug Dev Technol 2:497–506. doi:10.1089/adt.2004.2.497
Xu J, Guia A, Rothwarf D et al (2003) A benchmark study with SealChipTM planar patch-clamp technology. Assay Drug Dev Technol 1:675–684. doi:10.1089/154065803770381039
Stoelzle S, Obergrussberger A, Brüggemann A et al (2011) State-of-the-art automated patch clamp devices: heat activation, action potentials, and high throughput in ion channel screening. Front Pharmacol 2:1–11. doi:10.3389/fphar.2011.00076
Obergrussberger A, Haarmann C, Rinke I et al (2014) Automated patch clamp analysis of nAChα7 and NaV 1.7 channels. Curr Protoc Pharmacol 65:11.13.1–11.13.48. doi:10.1002/0471141755.ph1113s65
Schroeder K, Neagle B, Trezise DJ, Worley J (2003) IonWorks HT: a new high-throughput electrophysiology measurement platform. J Biomol Screen 8:50–64. doi:10.1177/1087057102239667
Finkel A, Wittel A, Yang N et al (2006) Population patch clamp improves data consistency and success rates in the measurement of ionic currents. J Biomol Screen 11:488–496. doi:10.1177/1087057106288050
Gillie DJ, Novick SJ, Donovan BT et al (2013) Development of a high-throughput electrophysiological assay for the human ether-à-go-go related potassium channel hERG. J Pharmacol Toxicol Methods 67:33–44. doi:10.1016/j.vascn.2012.10.002
Kuryshev YA, Brown AM, Duzic E, Kirsch GE (2014) Evaluating state dependence and subtype selectivity of calcium channel modulators in automated electrophysiology assays. Assay Drug Dev Technol 12:110–119. doi:10.1089/adt.2013.552
Scheel O, Himmel H, Rascher-Eggstein G, Knott T (2011) Introduction of a modular automated voltage-clamp platform and its correlation with manual human Ether-à-go-go related gene voltage-clamp data. Assay Drug Dev Technol 9:600–607. doi:10.1089/adt.2010.0352
Spencer CI, Li N, Chen Q et al (2012) Ion channel pharmacology under flow: automation via well-plate microfluidics. Assay Drug Dev Technol 10:313–324. doi:10.1089/adt.2011.414
Obergrussberger A, Stölzle-Feix S, Becker N et al (2015) Novel screening techniques for ion channel targeting drugs. Channels 9:367–375. doi:10.1080/19336950.2015.1079675
Obergrussberger A, Brüggemann A, Goetze TA et al (2015) Automated patch clamp meets high-throughput screening: 384 cells recorded in parallel on a planar patch clamp module. J Lab Autom. doi:10.1177/2211068215623209
Sager PT, Gintant G, Turner JR et al (2014) Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium. Am Heart J 167:292–300. doi:10.1016/j.ahj.2013.11.004
Fermini B, Hancox JC, Abi-Gerges N et al (2015) A new perspective in the field of cardiac safety testing through the comprehensive in vitro proarrhythmia assay paradigm. J Biomol Screen. doi:10.1177/1087057115594589
Cavero I, Holzgrefe H (2014) Comprehensive in vitro proarrhythmia assay, a novel in vitro/in silico paradigm to detect ventricular proarrhythmic liability: a visionary 21st century initiative. Expert Opin Drug Saf 13:745–758. doi:10.1517/14740338.2014.915311
Becker N, Stoelzle S, Göpel S et al (2013) Minimized cell usage for stem cell-derived and primary cells on an automated patch clamp system. J Pharmacol Toxicol Methods 68:82–87. doi:10.1016/j.vascn.2013.03.009
Rajamohan D, Kalra S, Hoang MD et al (2016) Automated electrophysiological and pharmacological evaluation of human pluripotent stem cell-derived cardiomyocytes. Stem Cells Dev 25. doi:10.1089/scd.2015.0253
Haythornthwaite A, Stoelzle S, Hasler A et al (2012) Characterizing human ion channels in induced pluripotent stem cell-derived neurons. J Biomol Screen 17:1264–1272. doi:10.1177/1087057112457821
Meijer van Putten RME, Mengarelli I, Guan K et al (2015) Ion channelopathies in human induced pluripotent stem cell derived cardiomyocytes: a dynamic clamp study with virtual IK1. Front Physiol 6:Article 7. doi:10.3389/fphys.2015.00007
Shen JB, Jiang B, Pappano AJ (2000) Comparison of L-type calcium channel blockade by nifedipine and/or cadmium in guinea pig ventricular myocytes. J Pharmacol Exp Ther 294:562–570
Klugbauer N, Lacinova L, Flockerzi V, Hofmann F (1995) Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells. EMBO J 14:1084–1090
Kass RS, Krafte DS (1987) Negative surface charge density near heart calcium channels. Relevance to block by dihydropyridines. J Gen Physiol 89:629–644. doi:10.1085/jgp.89.4.629
Charnet P, Bourinet E, Dubel SJ et al (1994) Calcium currents recorded from a neuronal alpha 1C L-type calcium channel in Xenopus oocytes. FEBS Lett 344:87–90
Sheets MF, Hanck DA (1999) Gating of skeletal and cardiac muscle sodium channels in mammalian cells. J Physiol 514(Pt 2):425–436
Acknowledgments
We thank Cellular Dynamics International (CDI), Madison, Wisconsin, for the collaboration and for providing us with cardiomyocytes (iCell cardiomyocytes). We also thank Axiogenesis AG, Cologne, Germany, for the collaboration and for providing us with cardiomyocytes (Cor.4U). We also thank Pluriomics for providing us with the Pluricytes.
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The work presented here was funded in part by the Bundesministerium fuer Bildung und Forschung (BMBF, grant 01QE1502).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Obergrussberger, A. et al. (2017). Automated Patch Clamp Recordings of Human Stem Cell-Derived Cardiomyocytes. In: Clements, M., Roquemore, L. (eds) Stem Cell-Derived Models in Toxicology. Methods in Pharmacology and Toxicology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6661-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6661-5_4
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6659-2
Online ISBN: 978-1-4939-6661-5
eBook Packages: Springer Protocols